20 years of rituximab treatment: what have we learnt?

Future Oncol. 2019 Dec;15(36):4119-4121. doi: 10.2217/fon-2019-0694. Epub 2019 Nov 13.
No abstract available

Keywords: B cell; biosimilar; immunotherapy; lymphoma; monoclonal antibody; rituximab.

Publication types

  • Editorial

MeSH terms

  • Animals
  • Antineoplastic Agents, Immunological / pharmacology
  • Antineoplastic Agents, Immunological / therapeutic use*
  • Humans
  • Lymphoma, B-Cell / diagnosis
  • Lymphoma, B-Cell / drug therapy*
  • Lymphoma, B-Cell / epidemiology
  • Molecular Targeted Therapy*
  • Rituximab / pharmacology
  • Rituximab / therapeutic use*
  • Treatment Outcome

Substances

  • Antineoplastic Agents, Immunological
  • Rituximab